Perfluorooctanoate Concentrations Research Articles

Perfluoroalkyl Acids in Great Lakes Precipitation and Surface Water (2006-2018) Indicate Response to Phase-outs, Regulatory Action, and Variability in Fate and Transport Processes.

The concentrations of perfluoroalkyl acids (PFAAs) were determined in precipitation from three locations across the Great Lakes between 2006 and 2018 and compared to those in surface water. Perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations generally decreased in precipitation, likely in response to phase-outs/regulatory actions. In comparison, concentrations of shorter-chained PFAA,whichare not regulated in Canada did not decrease and those of perfluorohexanoate and perfluorobutanoate (PFBA) recently increased, which could be due to their use as replacements, as the longer-chained PFAAs are being phased-out by industry. PFOS and PFOA concentrations were greater in Lake Ontario precipitation than in precipitation from more remote locations. In comparison, PFBA concentrations were comparable across locations, suggesting greater atmospheric transport either through its more volatile precursors and/or directly in association with particles/aerosols. In Lake Ontario, the comparison of PFAAs in precipitation to those in surface water provides evidence of sources (e.g., street dust and wastewater effluent) in addition to wet deposition to surface water, whereas wet deposition appears to be dominant in Lakes Huron and Superior. Our results suggest that source control of shorter-chained PFAAs may be slow to be reflected in environmental concentrations due to emissions far from the location of detection and continued volatilization from existing in-use products and waste streams.

Relationship between perfluorooctanoate and perfluorooctane sulfonate blood concentrations in the general population and routine drinking water exposure

In regions with heavily contaminated drinking water, a significant contribution of drinking water to overall human perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) exposure has been well documented. However, the relationship of PFOA/PFOS blood concentrations in the general population to routine drinking water exposure is not well characterized. This study determined the PFOA and PFOS concentrations in 166 drinking water samples across 28 cities in China. For 13 of the studied cities, PFOA and PFOS concentrations were analyzed in 847 human blood samples which were collected in parallel with the drinking water samples. The geometric mean PFOA and PFOS concentrations in drinking water were 2.5 ± 6.2 ng/L and 0.7 ± 11.7 ng/L, and population-weighted geometric mean blood concentrations were 2.1 ± 1.2 ng/mL and 2.6 ± 1.3 ng/mL, respectively. We found a significant correlation between the PFOA concentration in drinking water and blood (r = 0.87, n = 13, p < 0.001). The total daily intake of PFOA (0.24–2.13 ng/kg/day) and PFOS (0.19–1.87 ng/kg/day) were back-calculated from the blood concentrations with a one-compartment toxicokinetic model. We estimated relative source contributions (RSCs) of drinking water to total daily intake in China of 23 ± 3% for PFOA and 12.7 ± 5.8% for PFOS. Using the mean RSCs, we derived the health advisory values of 85 ng/L for PFOA and 47 ng/L for PFOS in China.

Simulating transport, flux, and ecological risk of perfluorooctanoate in a river affected by a major fluorochemical manufacturer in northern China

Perfluoroalkyl acids (PFAAs) have been widely detected and pose potential risks to both human and ecosystem health. Since the probation of perfluorooctane sulfonate (PFOS) by the Stockholm Convention, perfluorooctanoate (PFOA) has frequently been used as a chemical intermediate and processing aid. Owing to a lack of effective treatment technologies for PFOA, surrounding environments have been highly affected. Previous studies by our group have reported elevated PFOA levels in the Xiaoqing River, which receives sewage from a major fluorochemical manufacturer in northern China. To further explore the transport, flux, and ecological risk of the perfluorooctanoate in the river, this study conducted a 2-year sampling campaign of surface water from 2014 to 2015. An extremely high PFOA concentration (mean: 62.3 μg L−1) was observed for the Xiaoqing River in comparison with other studies. The highest average concentration and flux of PFOA were recorded in the autumn and summer, respectively. With data on selected hydrological parameters and cross-sections, PFOA concentrations were modeled using DHI MIKE 11. To explore the current loads and environmental capacity of PFOA, two scenarios (i.e., emissions based on observed concentrations and on the predicted no-effects concentration, PNEC) were set. The simulation results based on observed data showed that PFOA loads in the Xiaoqing River were 11.4 t in 2014, and 12.5 t in 2015. Based on the PNEC, the environmental carrying capacity of PFOA was estimated to be 13.9 t in 2014, and 13.8 t in 2015. The current loads of PFOA were found to approach the maximum environmental carrying capacity. Relatively high risks around both the fluorine industrial park (FIP) and estuary area were identified. In comparison with other suggested guidelines, threats to the ecological status of the river would be severe, which suggests that stringent management and emission criteria are needed for this industry.

Perfluorooctanoate and Perfluorooctanesulfonate plasma concentrations and survival after prostate and bladder cancer in a population-based study

Background: Perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) are synthetically produced chemicals, which have been linked to cancer in animal studies, whereas the evidence in humans is merely suggestive. We investigated the association between PFOA and PFOS concentrations in plasma samples and mortality in two survivor cohorts of prostate and bladder cancer patients. Methods: We included 688 prostate and 307 bladder cancer cases diagnosed between baseline (1993–97) and July 1, 2006 in the Danish Diet, Cancer and Health cohort. PFOA and PFOS concentrations in plasma samples taken at baseline were measured using high-pressure liquid chromatography. We used Cox proportional hazards models to estimate mortality rate ratios. Results: Between diagnosis and February 1, 2016, 356 prostate and 149 bladder cancer cases died. We found no association between PFOA or PFOS concentrations and survival among prostate cancer cases. This was regardless of prognostic factors. For bladder cancer cases, there was an inverse association between PFOA and PFOS and subsequent mortality. Associations were similar for both overall and bladder cancer-specific mortality. Conclusions: The results of the present study does not suggest an association between PFOA or PFOS concentrations and survival among prostate cancer patients. In contrast, they may be inversely associated with both overall and bladder cancer–specific mortality in bladder cancer patients. However, this finding requires replication in further studies before firm conclusions can be drawn.

Prenatal concentrations of perfluoroalkyl substances and bone health in British girls at age 17.

PFAS are used to make protective coatings on common household products. Prenatal exposures have been associated with developmental outcomes in offspring. Using data from the Avon Longitudinal Study of Parents and Children (ALSPAC), we investigated the association between prenatal concentrations of PFAS and bone health in girls at 17years of age and whether body composition can explain any associations. We measured concentrations of perfluorooctane sulfonate (PFOS), perfluorooctanoate (PFOA), perfluorohexane sulfonate (PFHxS), and perfluorononanoic acid (PFNA) in maternal serum samples collected during pregnancy. We obtained bone health outcomes in the girls, such as bone mineral density, bone mineral content, bone area, and area-adjusted bone mineral content from whole-body dual-energy X-ray absorptiometry (DXA) scans. We used multivariable linear regression to explore associations between each PFAS and each bone health outcome with adjustment for important confounders such as girls' age at clinic visit, maternal education, and gestational age at sample collection. We also controlled for girls' height and lean mass to explore the role body composition had on observed associations. Prenatal PFOS, PFOA, PFHxS, and PFNA concentrations were associated with inverse effects on bone size and mass after adjusting for important confounders. Conversely, PFNA was positively associated with area-adjusted bone mineral content. However, most significant associations attenuated after additional controlling for height and lean mass. Prenatal concentrations of some PFAS may be associated with reduced bone mass and size in adolescent girls, although it is not clear whether these associations are driven by body size.

Comprehension and perceptions of study participants upon receiving perfluoroalkyl substance exposure biomarker results.

Measurement of environmental biomarkers in biomedia is increasingly used as a method of exposure characterization in human population studies. Reporting the results of biomarker measurements back to study participants has been controversial, including questions of ethics and whether the study participants would want to receive and would understand the results. Recently we mailed individual measurements of two serum biomarkers, perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) to participants in three exposure studies of persons living in the Ohio River Valley, of whom 60 were parents of children who had been sampled. Many had serum concentrations of PFOA above the US population 95th percentile value. Reporting forms used in the three studies were somewhat different (either tables or charts for comparison to US population values) and varied in complexity. With all reports, we included information about concentrations of PFOA and PFOS in the general population, and a survey designed to ascertain the opinions of the study participants about the information they received. Approximately 33% (273/821) returned the survey, and of those, 96% reported that they were pleased that we had sent them the report. Most (86%) responded that the results were easy to understand and the enclosed fact sheet was helpful in answering questions (87%). Regarding the amount of information, most felt that we provided the "right amount" (78%) but some "too much" (7%) and some "too little" (15%). The majority (53%) were surprised at their serum concentrations. Of those with serum values > 13.0 ng/mL, 74% responded that they thought their serum concentration was "high", but only 22% of those with serum concentrations ≤5.6 responded that their concentration was "low". Surprisingly, many talked to no one about their levels; those who did were most likely to discuss the report with family members. Reporting back individual environmental biomarker results is generally well received by study participants, and those with high concentrations perceived them to be high. Questions remain as to why study participants did not discuss their results with others.

Perfluoroalkyl substances, glucose homeostasis, and gestational diabetes mellitus in Chinese pregnant women: A repeat measurement-based prospective study

BackgroundExposure to perfluoroalkyl substances (PFASs) can affect glucose homeostasis and has been suggested as a potential risk of diabetes mellitus, but data are limited for pregnant women. ObjectivesWe aimed to explore the associations of exposure to PFASs with glucose homeostasis and gestational diabetes mellitus (GDM) in Chinese pregnant women. MethodsThe current study was conducted in Hebei Province of Northern China between 2013 and 2014 and 560 pregnant women were recruited in their early term of pregnancy and two representative serum PFASs, perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS), were measured. In 385 pregnant women who completed oral glucose tolerance test (OGTT), the associations of serum PFOA and PFOS concentrations with fasting blood glucose (FBG), fasting insulin (FIns), and homeostasis model assessment of insulin resistance (HOMA-IR) in the early, middle, and late terms of pregnancy and occurrence of GDM were examined using linear and Cox proportional hazard regression models. The reproducibility of serum PFASs during pregnancy was assessed in 230 pregnant women. ResultsThe intraclass correlation coefficients of serum PFASs, covariates, and outcomes based on averaged repeat measurement (0.35–0.96) were higher than those based on single measurement (0.16–0.92). Serum PFOA was positively associated with averaged FIns and HOMA-IR in the early, middle, and late terms of pregnancy and averaged blood glucose level at 1 h and 2 h of OGTT, but serum PFOS tended to be negatively associated with averaged FBG and OGTT blood glucose. The adjusted hazard ratios of GDM associated with serum PFOA and PFOS were 1.98 (95% confidence interval: 0.70–5.57; p-value: 0.197) and 0.71 (0.29–1.75; 0.453), respectively. ConclusionsOur data raised a possibility that exposure to PFASs might have different influences on glucose homeostasis and GDM in Chinese pregnant women. More lab and human studies are needed to further test the hypothesis and investigate potential mechanisms.

Early life exposure to per- and polyfluoroalkyl substances and mid-childhood lipid and alanine aminotransferase levels

BackgroundGrowing evidence suggests that exposure to per- and polyfluoroalkyl substances (PFASs) may disrupt lipid homeostasis and liver function, but data in children are limited. ObjectiveWe examined the association of prenatal and mid-childhood PFAS exposure with lipids and alanine aminotransferase (ALT) levels in children. MethodsWe studied 682 mother-child pairs from a Boston-area pre-birth cohort. We quantified PFASs in maternal plasma collected in pregnancy (median 9.7weeks gestation, 1999–2002) and in child plasma collected in mid-childhood (median age 7.7years, 2007–2010). In mid-childhood we also measured fasting total (TC), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), and ALT. We then derived low-density lipoprotein cholesterol (LDL-C) from TC, HDL-C, and TG using the Friedewald formula. ResultsMedian (interquartile range, IQR) perfluorooctane sulfonate (PFOS), perfluorooctanoate (PFOA), and perfluorodecanoate (PFDeA) concentrations in child plasma were 6.2 (5.5), 4.3 (3.0), and 0.3 (0.3) ng/mL, respectively. Among girls, higher child PFOS, PFOA, and PFDeA concentrations were associated with detrimental changes in the lipid profile, including higher TC and/or LDL-C [e.g., β per IQR increment in PFOS=4.0mg/dL (95% CI: 0.3, 7.8) for TC and 2.6mg/dL (−0.5, 5.8) for LDL-C]. However, among both boys and girls, higher plasma concentrations of these child PFASs were also associated with higher HDL-C, which predicts better cardiovascular health, and slightly lower ALT, which may indicate better liver function. Prenatal PFAS concentrations were also modestly associated with improved childhood lipid and ALT levels. ConclusionsOur data suggest that prenatal and mid-childhood PFAS exposure may be associated with modest, but somewhat conflicting changes in the lipid profile and ALT levels in children.

Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort

BackgroundPrenatal perfluorooctanoate (PFOA) exposure has been associated with reduced birth weight but maternal glomerular filtration rate (GFR) may attenuate this association. Further, this association remains unclear for other perfluoroalkyl substances (PFAS), such as perfluorooctane sulfonate (PFOS), perfluorohexane sulfonate (PFHxS), and perfluorononanoate (PFNA). We estimated associations between prenatal PFAS exposure and birth outcomes, and the influence of GFR, in a Spanish birth cohort. MethodsWe measured PFHxS, PFOS, PFOA, and PFNA in 1st-trimester maternal plasma (years: 2003–2008) in 1202 mother-child pairs. Continuous birth outcomes included standardized weight, length, head circumference, and gestational age. Binary outcomes included low birth weight (LBW), small-for-gestational-age, and preterm birth. We calculated maternal GFR from plasma-creatinine measurements in the 1st-trimester of pregnancy (n=765) using the Cockcroft-Gault formula. We used mixed-effects linear and logistic models with region of residence as random effect and adjustment for maternal age, parity, pre-pregnancy BMI, and fish intake during pregnancy. ResultsNewborns in this study weighted on average 3263g and had a median gestational age of 39.8weeks. The most abundant PFAS were PFOS and PFOA (median: 6.05 and 2.35ng/mL, respectively). Overall, PFAS concentrations were not significantly associated to birth outcomes. PFOA, PFHxS, and PFNA showed weak, non-statistically significant associations with reduced birth weights ranging from 8.6g to 10.3g per doubling of exposure. Higher PFOS exposure was associated with an OR of 1.90 (95% CI: 0.98, 3.68) for LBW (similar in births-at-term) in boys. Maternal GFR did not confound the associations. ConclusionsIn this study, PFAS showed little association with birth outcomes. Higher PFHxS, PFOA, and PFNA concentrations were non-significantly associated with reduced birth weight. The association between PFOS and LBW seemed to be sex-specific. Finally, maternal GFR measured early during pregnancy had little influence on the estimated associations.

Molecular Mechanisms of Perfluorooctanoate-Induced Hepatocyte Apoptosis in Mice Using Proteomic Techniques.

The stability of perfluorooctanoate (PFOA) coupled with its wide use cause serious concerns regarding its potential risk to human health. The molecular mechanisms of PFOA-induced hepatotoxicity relevant to human health was investigated using both in vivo (mouse model) and in vitro (human hepatocyte cells, HL-7702) techniques. Both male and female Balb/c mice were administered PFOA at 0.05, 0.5, or 2.5 mg/kg-d for 28-d, with serum PFOA concentrations after exposure being found at environmentally relevant levels. Liver samples were examined for histology and proteomic change using iTRAQ and Western Blotting, showing dose-dependent hepatocyte apoptosis and peroxisome proliferation. At high doses, genotoxicity resulting from ROS hypergeneration was due to suppression of Complex I subunits in the electron transport chain and activation of PPARα in both genders. However, at 0.05 mg/kg-d, Complex I suppression occurred only in females, making them more sensitive to PFOA-induced apoptosis. In vitro assays using HL-7702 cells confirmed that apoptosis was also induced through a similar mechanism. The dose/gender-dependent toxicity mechanisms help to explain some epidemiological phenomena, i.e., liver cancer is not often associated with PFOA exposure in professional workers. Our results demonstrated that a proteomic approach is a robust tool to explore molecular mechanisms of toxic chemicals at environmentally relevant levels.

Per- and polyfluoroalkyl substances (PFAS) in American Red Cross adult blood donors, 2000–2015

In 2015, thirteen per- and polyfluoroalkyl substances (PFAS), including perfluorohexanesulfonate (PFHxS), perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), perfluorononanoate (PFNA), and perfluorodecanoate (PFDA) were analyzed in human plasma that were collected from a total of 616 American Red Cross male and female blood donors (ages 20–69) at 6 regional blood collection centers. Plasma samples were analyzed using a validated solvent precipitation-isotope dilution direction-liquid chromatography tandem mass spectrometry method. The data were analyzed in conjunction with prior cross-sectional investigations [2000–2001 (n =645), 2006 (n =600), and 2010 (n =600)] to determine PFAS trends. Age- and sex-adjusted geometric mean serum (2000–2001) and plasma (2006, 2010, 2015) concentrations (ng/mL) were, respectively: PFHxS (2.3, 1.5, 1.3, 0.9); PFOS (35.1, 14.5, 8.4, 4.3); PFOA (4.7, 3.4, 2.4, 1.1); PFNA (0.6, 1.0, 0.8, 0.4); and PFDA (0.2, 0.3, 0.3, 0.1). The percentage decline in these geometric mean concentrations from 2000–2001 to 2015 were: PFHxS (61%); PFOS (88%); PFOA (77%); PFNA (33%); and PFDA (50%). The results indicate a continued decline of PFHxS, PFOS, and PFOA concentrations in American Red Cross blood donors. For the remaining PFAS measured in 2015, including the shorter chain perfluoroalkyls perfluorobutanesulfonate (PFBS) and perfluorohexanoate (PFHxA), the majority of samples were below the lower limit of quantitation.

Accumulation of Perfluoroalkylated Substances in Oceanic Plankton.

The bioaccumulation of perfluoroalkylated substances (PFASs) in plankton has previously been evaluated only in freshwater and regional seas, but not for the large oligotrophic global oceans. Plankton samples from the tropical and subtropical Pacific, Atlantic and Indian Oceans were collected during the Malaspina 2010 circumnavigation expedition, and analyzed for 14 ionizable PFASs, including perfluorooctanoate (PFOA), perfluorooctanesulfonate (PFOS) and their respective linear and branched isomers. PFOA and PFOS concentrations in plankton ranged from 0.1 to 43 ng gdw-1 and from 0.5 to 6.7 ng gdw-1, respectively. The relative abundance of branched PFOA in the northern hemisphere was correlated with distance to North America, consistent with the historical production and coherent with previously reported patterns in seawater. The plankton samples showing the highest PFOS concentrations also presented the largest relative abundances of branched PFOS, suggesting a selective cycling/fractionation of branched PFOS in the surface ocean mediated by plankton. Bioaccumulation factors (BAFs) for plankton were calculated for six PFASs, including short chain PFASs. PFASs Log BAFs (wet weight) ranged from 2.6 ± 0.8 for perfluorohexanesulfonic acid (PFHxS), to 4.4 ± 0.6 for perfluoroheptanoic acid (PFHpA). The vertical transport of PFASs due to the settling of organic matter bound PFAS (biological pump) was estimated from an organic matter settling fluxes climatology and the PFAS concentrations in plankton. The global average sinking fluxes were 0.8 ± 1.3 ng m-2d-1 for PFOA, and 1.1 ± 2.1 ng m-2d-1 for PFOS. The residence times of PFAS in the surface ocean, assuming the biological pump as the unique sink, showed a wide range of variability, from few years to millennia, depending on the sampling site and individual compound. Further process-based studies are needed to constrain the oceanic sink of PFAS.

ADONA and perfluoroalkylated substances in plasma samples of German blood donors living in South Germany.

Perfluorinated compounds are fully fluorinated anthropogenic substances that have been used in various products, applications, and industrial processes. Due to their persistence and toxic effects, some of them are restricted, and therefore replacement products have been developed. The aim of the study was to quantify the body burden of different perfluorinated substances in two adult populations living close to or about 80km apart from a former perfluorooctanoate (PFOA) production plant who are exposed via drinking water, and in a control population. In this plant, the replacement emulsifier 3H-perfluoro-3-[(3-methoxy-propoxy)propanoic acid] (ADONA) has been used in the production of fluoropolymers since 2008. We quantified 7 perfluorinated compounds and ADONA in a total of 396 plasma samples collected at different time points. With regard to samples collected in 2015 or 2016, the highest 95th percentile levels were 13.5μg/l for perfluorooctane sulfonate (PFOS), 3.0μg/l for perfluorononanoate (PFNA), and 1.5μg/l for perfluorohexane sulfonate (PFHxS). For PFOA, the highest 95th percentile was found at the site close to the facility (85.5μg/l), while in the control region the value was 2.4μg/l. Overall, the concentration of PFOA and PFOS declined over time in all study regions. ADONA was detected only in few samples slightly above the limit of quantification (0.2μg/l). While health risks related to ADONA are unlikely under the present exposure situation, the exposure to PFOA via tap water should be reduced markedly, especially for the population living close to the plant.

Recovery of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) from dilute water solution by foam flotation

Abstract The separation and recovery of surfactants, namely, Perfluorooctane sulfonate (PFOS) and Perfluorooctanoate (PFOA) was conducted using foam flotation process aided by metallic activators, including Al(III), Fe(III), La(III), Ca(II), Fe(II), and K(I). The PFOS removal efficiency followed the following decreasing order: Fe(III) ⩾ La(III) > Al(III) > Ca(II) > Fe(II) > K(I). Both PFOS and FPOA had a removal efficiency of >99% in the presence of 11.5 mM of Fe(III) in 5 min. High Fe(III) dose and elevated initial PFOS and PFOA concentration enhanced surfactant removal. PFOS and PFOA removal also increased with decreasing pH with maximum removal occurring at the lowest pH of 2.3 studied; whereas no significant removal was observed at pH ⩾ 6. At high pH, hydroxide ion (OH−) competed with PFOS or PFOA for Fe3+ and formed ferric hydroxo species that impeded surfactant removal. However, by adjusting the pH of the concentrate scum to 7.0, approximately 84–91% of PFOS and PFOA could be recovered. Foam flotation using ferric ion as activator, is a simple, fast, and cost-effective method of broad environmental-friendly applications for the separation and recovery of PFOS and PFOA from dilute water solutions.

Impacts of geocoding uncertainty on reconstructed PFOA exposures and their epidemiological association with preeclampsia

Many epidemiology studies have investigated associations of perfluorooctanoate (PFOA) exposures with a variety of adverse health outcomes for participants in the C8 Health Project. The exposure concentrations (i.e., air and groundwater) used in these studies were determined primarily based on participant’s residential locations. However, for residential addresses that could not be geocoded to the street level, the exposure concentrations were assigned based on population-weighted ZIP code centroid, which may result in exposure mischaracterization. The aim of this current study is to evaluate the potential impact of mischaracterized exposure concentrations due to geocoding uncertainty on the predicted serum PFOA concentrations and the epidemiological association between PFOA exposure and preeclampsia. For both workplace addresses and incompletely geocoded residential addresses, we used Monte Carlo (MC) simulation to assign alternate geographic locations within the reported ZIP code (instead of population-weighted ZIP code centroids) and the corresponding exposure concentrations. We found that mischaracterization of residential exposure due to population-weighted ZIP code centroid assignment had no significant impact on the serum PFOA concentration predictions and the epidemiological association of PFOA exposure with preeclampsia. In contrast, the uncertainty in workplace exposure moderately impacted the rank exposure among the participants. We observed a 41% increase in the average adjusted odds ratio of preeclampsia occurrence that may be due to differing proportions of cases (64.3%) and controls (54.5%) with workplace address geocodes during pregnancy. This finding suggests that differential exposure mischaracterization can be reduced by obtaining accurate exposure information such as street addresses and tap water consumption, for both workplaces and residences. The analysis we present is one approach for estimating the potential impacts of positional errors in a geocoding-based exposure assessment on exposure estimates and epidemiological study results.

A pilot study of prenatal exposure to perfluoroalkyl substances and social cognition

Background: Perfluoroalkyl substances (PFASs) are ubiquitous, persistent chemicals used in stain and water resistant products. Animal studies suggest that PFASs are neurodevelopmental toxicants, but epidemiologic studies are inconsistent in their findings of exposure-associated changes in children’s cognition and behavior. Objective: To investigate the association of prenatal PFASs with social cognition, a measure of how individuals perceive and respond to social cues, which is impaired in individuals with autism spectrum disorders (ASD). Methods: We collected pilot data from 52 mother-adolescent pairs participating in Project Viva, a longitudinal pre-birth cohort enrolled 1999‒2002, in which we measured perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) in maternal plasma collected in early gestation (median=9.4 weeks). Parents rated their children using the Social Responsiveness Scale Version 2 (SRS-2). Results: Mean (interquartile range [IQR]) PFOA and PFOS concentrations were 6.6 ng/ml (3.4) and 30.7 ng/mL (16.6), respectively; mean (range) child age was 14 years (12-15) and mean (SD) SRS-2 score was 23.2 (19.4). In multivariable linear regression adjusted for maternal education and household income, for each IQR increment of prenatal PFOA and PFOS SRS-2 score was higher (poorer social cognition) by 5.2 points (95% CI: 0.9, 9.5) and 5.7 points (1.2, 10.4), respectively. We observed similar associations with the two SRS-derived DSM-V compatible subscales, Social Communication &amp; Interaction and Restricted Interests &amp; Repetitive Behavior. Discussion: Prenatal exposure to PFOA and PFOS was associated with poorer social cognition in a pilot sample of adolescents; estimating associations in the larger cohort will increase precision. Examining quantitative traits like social cognition rather than dichotomous diagnosis offers a statistically powerful and perhaps more valid approach to studying modifiable environmental risk factors for ASD.

A North American and global survey of perfluoroalkyl substances in surface soils: Distribution patterns and mode of occurrence

The distribution of 32 per/polyfluoroalkyl substances (PFASs) in surface soils was determined at 62 locations representing all continents (North America n = 33, Europe n = 10, Asia n = 6, Africa n = 5, Australia n = 4, South America n = 3 and Antarctica n = 1) using ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) systems. Quantifiable levels of perfluoroalkyl carboxylates (PFCAs: PFHxA-PFTeDA) were observed in all samples with total concentrations ranging from 29 to 14,300 pg/g (dry weight), while perfluoroalkane sulfonates (PFSAs: PFHxS, PFOS and PFDS) were detected in all samples but one, ranging from <LOQ-3270 pg/g, confirming the global distribution of PFASs in terrestrial settings. The geometric mean PFCA and PFSA concentrations were observed to be higher in the northern hemisphere (930 and 170 pg/g) compared to the southern hemisphere (190 and 33 pg/g). Perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) were the most commonly detected analytes at concentrations up to 2670 and 3100 pg/g, respectively. The sum of PFCA homologues of PFOA commonly were roughly twice the concentration of PFOA. The PFCA and PFSA congener profiles were similar amongst most locations, with a few principal-component statistical anomalies suggesting impact from nearby urban and point sources. The ratio of even to odd PFCAs was consistent with the atmospheric oxidation of fluorotelomer-based precursors previously observed in laboratory and environmental studies. Given the soils were collected from locations absent of direct human activity, these results suggest that the atmospheric long-range transport (LRT) of neutral PFASs followed by oxidation and deposition are a significant source of PFCAs and PFSAs to soils.

Association of perfluorinated chemical exposure in utero with maternal and infant thyroid hormone levels in the Sapporo cohort of Hokkaido Study on the Environment and Children's Health.

Perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) have been widely used as industrial products, and are persistent organic pollutants due to their chemical stability. Previous studies suggested that PFOS and PFOA might disrupt thyroid hormone (TH) status. Although TH plays an important role in fetal growth during pregnancy, little attention has been paid to the relationships between maternal exposure to perfluorocarbons and TH statuses of mothers and fetuses. We investigated the effects of low levels of environmental PFOS and PFOA on thyroid function of mothers and infants. Of the eligible subjects in a prospective cohort, 392 mother-infant pairs were selected. Concentration of maternal serum PFOS and PFOA was measured in samples taken during the second and third trimesters or within 1week of delivery. Blood samples for measuring thyroid stimulating hormone (TSH) and free thyroxine (FT4) levels were obtained from mothers at early gestational stage (median 11.1weeks), and from infants between 4 and 7days of age, respectively. Median concentrations of PFOS and PFOA were 5.2 [95% confidence interval (CI) 1.6-12.3] and 1.2 (95% CI limitation of detection-3.4) ng/mL, respectively. Maternal PFOS levels were inversely correlated with maternal serum TSH and positively associated with infant serum TSH, whereas maternal PFOA showed no significant relationship with TSH or FT4 among mothers and infants. These findings suggest that PFOS may independently affect the secretion and balances of maternal and infant TSH even at low levels of environmental exposure.

Perfluoroalkyl Substances, Sex Hormones, and Insulin-like Growth Factor-1 at 6-9 Years of Age: A Cross-Sectional Analysis within the C8 Health Project.

Background:Exposure to some perfluoroalkyl substances (PFAS), such as perfluorohexane sulfonate (PFHxS), perfluorooctanoate (PFOA), perfluorooctane sulfonate (PFOS), and perfluorononanoic acid (PFNA), may alter levels of sex hormones and insulin-like growth factor-1 (IGF-1) in animals. Human studies on this topic are scarce, and none have been conducted in young children.Objectives:We investigated the relationship between levels of PFAS and estradiol, total testosterone, and IGF-1 in 2,292 children (6–9 years of age) from the C8 Health Project who lived near a chemical plant in the Mid-Ohio Valley (USA) with local contamination from PFOA.Methods:Serum samples were collected in 2005–2006 and analyzed for PFAS, sex hormones, and IGF-1. Results from regression models were expressed as the adjusted percentage difference (95% CI) per sex-specific interquartile range (IQR) increment of each PFAS serum concentration. Analyses by PFAS quartiles were also conducted.Results:Median concentrations of PFHxS, PFOA, PFOS, and PFNA were 8, 35, 22, and 1.7 ng/mL in boys and 7, 30, 21, and 1.7 ng/mL in girls. In boys, PFOA concentrations were significantly associated with testosterone levels (–4.9%; 95% CI: –8.7, –0.8%); PFOS with estradiol (–4.0%; 95% CI: –7.7, –0.1%), testosterone (–5.8%; 95% CI: –9.4, –2.0%), and IGF-1 (–5.9%; 95% CI: –8.3, –3.3%); and PFNA with IGF-1 (–3.5%; 95% CI: –6.0, –1.0%). In girls, significant associations were found between PFOS and testosterone (–6.6%; 95% CI: –10.1, –2.8%) and IGF-1 (–5.6%; –8.2, –2.9%); and PFNA and IGF-1 (–3.8%; 95% CI: –6.4, –1.2%). In both sexes, the magnitudes of the associations decreased monotonically across quartiles for both testosterone and IGF-1 in relation to PFOS, and for IGF-1 and PFNA in girls.Conclusions:To our knowledge, this is the first study suggesting that PFAS are associated with lower levels of IGF-1 and sex hormones in young children.Citation:Lopez-Espinosa MJ, Mondal D, Armstrong BG, Eskenazi B, Fletcher T. 2016. Perfluoroalkyl substances, sex hormones, and insulin-like growth factor-1 at 6–9 years of age: a cross-sectional analysis within the C8 Health Project. Environ Health Perspect 124:1269–1275; http://dx.doi.org/10.1289/ehp.1509869

Variability and epistemic uncertainty in water ingestion rates and pharmacokinetic parameters, and impact on the association between perfluorooctanoate and preeclampsia in the C8 Health Project population

We recently utilized a suite of environmental fate and transport models and an integrated exposure and pharmacokinetic model to estimate individual perfluorooctanoate (PFOA) serum concentrations, and also assessed the association of those concentrations with preeclampsia for participants in the C8 Health Project (a cross-sectional study of over 69,000 people who were environmentally exposed to PFOA near a major U.S. fluoropolymer production facility located in West Virginia). However, the exposure estimates from this integrated model relied on default values for key independent exposure parameters including water ingestion rates, the serum PFOA half-life, and the volume of distribution for PFOA. The aim of the present study is to assess the impact of inter-individual variability and epistemic uncertainty in these parameters on the exposure estimates and subsequently, the epidemiological association between PFOA exposure and preeclampsia. We used Monte Carlo simulation to propagate inter-individual variability/epistemic uncertainty in the exposure assessment and reanalyzed the epidemiological association. Inter-individual variability in these parameters mildly impacted the serum PFOA concentration predictions (the lowest mean rank correlation between the estimated serum concentrations in our study and the original predicted serum concentrations was 0.95) and there was a negligible impact on the epidemiological association with preeclampsia (no change in the mean adjusted odds ratio (AOR) and the contribution of exposure uncertainty to the total uncertainty including sampling variability was 7%). However, when epistemic uncertainty was added along with the inter-individual variability, serum PFOA concentration predictions and their association with preeclampsia were moderately impacted (the mean AOR of preeclampsia occurrence was reduced from 1.12 to 1.09, and the contribution of exposure uncertainty to the total uncertainty was increased up to 33%). In conclusion, our study shows that the change of the rank exposure among the study participants due to variability and epistemic uncertainty in the independent exposure parameters was large enough to cause a 25% bias towards the null. This suggests that the true AOR of the association between PFOA and preeclampsia in this population might be higher than the originally reported AOR and has more uncertainty than indicated by the originally reported confidence interval.